Endoscopic requirements of colorectal cancer screening programs in average-risk population. Estimation according to a Markov model

Gastroenterologia y Hepatologia

Volumn 31, Issue 7, 2008, Pages 405-412

  Rodríguez Moranta, Francisco ^a   Trapero Bertran, Marta ^a   Castells, Antoni ^a,b   Mas Canal, Xavier ^a   Balaguer, Francesc ^a   Pellisé, Maria ^a   Gonzalo, Victòria ^a   Ocaña, Teresa ^a   Trilla, Antoni ^a   Piqué, Josep M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMA; ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER SCREENING; CANCER SURVIVAL; COLONOSCOPY; COLORECTAL CANCER; GROUPS BY AGE; HIGH RISK POPULATION; HUMAN; INCIDENCE; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; OCCULT BLOOD; PATIENT COMPLIANCE; PROBABILITY; SIGMOIDOSCOPY; COLORECTAL TUMOR; FEASIBILITY STUDY; MASS SCREENING; MIDDLE AGED; PATHOLOGY; RISK FACTOR; STATISTICS;

AGED; COLORECTAL NEOPLASMS; FEASIBILITY STUDIES; HUMANS; MARKOV CHAINS; MASS SCREENING; MIDDLE AGED; RISK FACTORS; SIGMOIDOSCOPY;

EID: 58149389589     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1157/13125585     Document Type: Article

References (53)

1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000: Cancer incidence, mortality and prevalence worldwide. 10th ed: Lyon: IARCPress; 2001.
2. Gatta G, Capocaccia R, Sant M, Bell CM, Coebergh JW, Damhuis RA, et al. Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut. 2000;47:533-8.
3. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin. 2003;53:5-26.
4. Rustgi AK. Hereditary gastrointestinal polyposis and nonpolyposis syndromes. N Engl J Med. 1994;331:1694-702.
5. Piñol V, Castells A, Andreu M, Castellvi-Bel S, Alenda C, Llor X, et al. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA. 2005;293:1986-94.
6. Burt R, Neklason DW. Genetic testing for inherited colon cancer. Gastroenterology. 2005;128:1696-716.
7. Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology. 2003;124:544-60.
8. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:1603-7.
9. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst. 1999;91:434-7.
10. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328:1365-71.
11. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467-71.
12. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472-7.
13. Scholefield JH, Moss S, Sufi F, Mangham CM, Hardcastle JD. Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial. Gut. 2002;50:840-4.
14. Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med. 1992;326:658-62.
15. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653-7.
16. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992;84:1572-5.
17. Newcomb PA, Storer BE, Morimoto LM, Templeton A, Potter JD. Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. J Natl Cancer Inst. 2003;95:622-5.
18. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med. 2000;343:162-8.
19. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med. 2000;343:169-74.
20. Regula J, Rupinski M, Kraszewska E, Polkowski M, Pachlewski J, Orlowska J, et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med. 2006;355:1863-72.
21. Muller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med. 1995;155:1741-8.
22. Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA. 2000;284:1954-61.
23. Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med. 2002;137:132-41.
24. Pignone M, Saha S, Hoerger T, Mandelblatt J. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the US Preventive Services Task Force. Ann Intern Med. 2002;137:96-104.
25. Castells A, Marzo M, Bellas B, Amador F, Lanas A, Mascort J, et al. Guía de práctica clínica en prevención del cáncer colorrectal. Gastroenterol Hepatol. 2004;27:573-634.
26. Fisher JA, Fikry C, Troxel AB. Cutting cost and increasing access to colorectal cancer screening: another approach to following the guidelines. Cancer Epidemiol Biomarkers Prev. 2006;15:108-13.
27. Europeas CdlC. Propuesta de Recomendación del Consejo sobre cribado del cáncer. Volume 2003/878/CE, 2003: 327/34L-327/37L.
28. Gross CP, McAvay GJ, Krumholz HM, Paltiel AD, Bhasin D, Tinetti ME. The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: implications for screening. Ann Intern Med. 2006;145:646-53.
29. Estadística INd. Proyecciones y estimaciones intercensales de población. Madrid: Instituto Nacional de Estadística; 2005.
30. Census USBot. US Bureau of the Census (2004). Table 094. Midyear Population, by Age and Sex. Spain 2005 up to 2030 [accessed 2 Ago 2004]. Available from: http://www.census.gov/cgi-bin/ipc/idbagg
31. Ardanaz E, Moreno C, Pérez de Rada ME, Ezponda C, Agorreta A, Floristán Y, et al. Incidence and mortality of cancer in Navarra, 1993-1997. Tendencies in the last 25 years. An Sist Sanit Navar. 2001;24:339-62.
32. Winawer SJ, Zauber AG, Fletcher RH, Stillman JS, O'Brien MJ, Levin B, et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology. 2006;130:1872-85.
33. Benson AB 3rd, Desch CE, Flynn PJ, Krause C, Loprinzi CL, Minsky BD, et al. 2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines. J Clin Oncol. 2000;18:3586-8.
34. Desch CE, Benson AB 3rd, Somerfield MR, Flynn PJ, Krause C, Loprinzi CL, et al. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol. 2005;23:8512-9.
35. Campo R, Brullet E, Junquera F, Puig-Divi V, Vergara M, Calvet X, et al. Sedation in digestive endoscopy. Results of a hospital survey in Catalonia (Spain). Gastroenterol Hepatol. 2004;27:503-7.
36. Segnan N, Senore C, Andreoni B, Aste H, Bonelli L, Crosta C, et al. Baseline findings of the Italian multicenter randomized controlled trial of «once-only sigmoidoscopy», SCORE. J Natl Cancer Inst. 2002;94:1763-72.
37. Bombi JA. Polyps of the colon in Barcelona, Spain. An autopsy study. Cancer. 1988;61:1472-6.
38. Arminski TC, McLean DW. Incidence and distribution of adenomatous polyps of the colon and rectum based on 1,000 autopsy examinations. Dis Colon Rectum. 1964;19:249-61.
39. Rickert RR, Auerbach O, Garfinkel L, Hammond EC, Frasca JM. Adenomatous lesions of the large bowel: an autopsy survey. Cancer. 1979;43:1847-57.
40. Vatn MH, Stalsberg H. The prevalence of polyps of the large intestine in Oslo: an autopsy study. Cancer. 1982;49:819-25.
41. Eide TJ, Stalsberg H. Polyps of the large intestine in Northern Norway. Cancer. 1978;42:2839-48.
42. Ladabaum U, Song K. Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand. Gastroenterology. 2005;129:1151-62.
43. Jarvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomaki P, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary non-polyposis colorectal cancer. Gastroenterology. 2000;118:829-34.
44. Burt RW. Colon cancer screening. Gastroenterology. 2000;119:837-53.
45. Seeff LC, Richards TB, Shapiro JA, Nadel MR, Manninen DL, Given LS, et al. How many endoscopies are performed for colorectal cancer screening? Results from CDC's survey of endoscopic capacity. Gastroenterology. 2004;127:1670-7.
46. Sala M, Castells A, Bessa X, Gargallo L, Piqué JM. Screening for colorectal cancer in Catalonia. Results of a population survey. Gastroenterol Hepatol. 1998;21:427-31.
47. Seeff LC, Manninen DL, Dong FB, Chattopadhyay SK, Nadel MR, Tangka FK, et al. Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States? Gastroenterology. 2004;127:1661-9.
48. Balaguer F, Llach J, Castells A, Bordas JM, Pellisé M, Rodríguez-Moranta F, et al. The European panel on the appropriateness of gastrointestinal endoscopy guidelines colonoscopy in an open-access endoscopy unit: a prospective study. Aliment Pharmacol Ther. 2005;21:609-13.
49. Atkin WS, Cuzick J, Northover JM, Whynes DK. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet. 1993;341:736-40.
50. Schoenfeld P, Lipscomb S, Crook J, Domínguez J, Butler J, Holmes L, et al. Accuracy of polyp detection by gastroenterologists and nurse endoscopists during flexible sigmoidoscopy: a randomized trial. Gastroenterology. 1999;117:312-8.
51. Schroy PC, Heeren T, Bliss CM, Pincus J, Wilson S, Prout M. Implementation of on-site screening sigmoidoscopy positively influences utilization by primary care providers. Gastroenterology. 1999;117:304-11.
52. Sonnenberg A, Delco F. Cost-effectiveness of a single colonoscopy in screening for colorectal cancer. Arch Intern Med. 2002;162:163-8.
53. Faivre J, Dancourt V, Lejeune C, Tazi MA, Lamour J, Gerard D, et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology. 2004;126:1674-80.